Astera Labs stock slipped 4.4% to US$223.27 in the first full session after reporting Q3 2026, extending a choppy few weeks for the ticker. Traders focused on the immediate hit. The numbers told a different story. Revenue reached US$584.9m and basic earnings per share printed at US$1.05, both tied to accelerating demand for its AI connectivity hardware.
In the short term, the chart looks bruised. Over a multi year lens, investors are weighing a business that now runs at more than US$1.5b in trailing twelve month sales against a rich valuation and growing scrutiny of earnings quality.
Love Astera Labs’ rapid top line progress but uneasy about paying up while earnings quality is under the microscope? Scan the 34 high quality undervalued stocks to compare ALAB with companies that pair strong fundamentals and cleaner valuations.
Scorpio just became Astera Labs’ biggest business with a $1B run-rate. Ask Charlie what makes Astera’s Scorpio AI fabric so different.
Astera Labs’ bullish story rests on becoming the connective tissue across the whole AI rack, rather than focusing on a single socket.
"The Orion rack-scale reference architecture for AI inference pods, which supports up to 160 accelerators and is designed around open, standards-based connectivity, gives Astera Labs a template to influence full-rack designs rather than single boards."
Q3 progress aligns partly with that goal. Scorpio X has already crossed a US$1b annualized run rate, and management now discusses evolving into a rack scale infrastructure supplier. Orion 1.0 is designed at around US$100k of Astera content per 80-accelerator rack, with targeted OEM and ODM shipments in 2027.
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for.
Bears argue Astera Labs is locking itself into a capped profitability model even as it loads more content into each AI system.
"However, management’s reiterated long term gross margin target near 70% suggests that the broader portfolio and richer module content could structurally cap net margin progression even if revenue grows."
This quarter does not yet show that cap biting. Non GAAP gross margin printed 72.4% and management guided roughly 72% again for Q4, with non GAAP operating margin near 45%. The missed milestone is different. There is still no tighter long term margin framework or updated free cash flow bridge that would confirm how quickly earnings could compress back toward that 70% guide as optical and Leo ramps begin.
Astera Labs just reported earnings that showed how a sharp fundamental story can still lead to volatile short term trading. The real opportunity could sit in stocks that appear undervalued as fundamentals progress and sentiment gradually adjusts.
Three companies from the same screener. Open the full list of 34 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com